Skip to content
Back to Guavy Wire
Stocks

Amgen Loses Institutional Support as Evolve Private Wealth Cuts Stake

Instruments
AMGN
Share

Evolve Private Wealth LLC has reduced its stake in Amgen Inc. (NASDAQ:AMGN) by 63.9% in the second quarter, selling 3,508 shares and trimming its holdings to 1,980 shares worth $717,000 as of its most recent SEC filing.

The firm's reduction comes amidst other institutional investors making changes to their positions in Amgen. Adell Harriman & Carpenter Inc. raised its stake by 7.9% during the fourth quarter and now owns 22,008 shares valued at $7,204,000 after buying an additional 1,609 shares.

Amgen's commercial portfolio includes biologics used in oncology, supportive care, nephrology, bone health, and cardiovascular disease. The company has set its FY 2026 guidance at 22.300-23.500 EPS.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc